These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 20196140

  • 1. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M, McCreary AC, Wydra K, Filip M.
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [Abstract] [Full Text] [Related]

  • 2. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):156-65. PubMed ID: 17617403
    [Abstract] [Full Text] [Related]

  • 3. Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.
    Zaniewska M, McCreary AC, Filip M.
    Synapse; 2009 Aug 01; 63(8):653-61. PubMed ID: 19347958
    [Abstract] [Full Text] [Related]

  • 4. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL, Rizos Z, Diwan M, Nobrega JN, Fletcher PJ.
    Behav Brain Res; 2013 Mar 01; 240():171-81. PubMed ID: 23201361
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
    Fletcher PJ, Grottick AJ, Higgins GA.
    Neuropsychopharmacology; 2002 Oct 01; 27(4):576-86. PubMed ID: 12377394
    [Abstract] [Full Text] [Related]

  • 6. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
    Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH.
    J Pharmacol Exp Ther; 2010 Dec 01; 335(3):728-34. PubMed ID: 20858706
    [Abstract] [Full Text] [Related]

  • 7. Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal.
    Zaniewska M, McCreary AC, Wydra K, Filip M.
    Neuropharmacology; 2010 Jun 01; 58(7):1140-6. PubMed ID: 20153341
    [Abstract] [Full Text] [Related]

  • 8. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
    Fletcher PJ, Rizos Z, Noble K, Soko AD, Silenieks LB, Lê AD, Higgins GA.
    Neuropharmacology; 2012 Jun 01; 62(7):2288-98. PubMed ID: 22342986
    [Abstract] [Full Text] [Related]

  • 9. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
    Damjanoska KJ, Muma NA, Zhang Y, D'Souza DN, Garcia F, Carrasco GA, Kindel GH, Haskins KA, Shankaran M, Petersen BR, Van De Kar LD.
    J Pharmacol Exp Ther; 2003 Mar 01; 304(3):1209-16. PubMed ID: 12604698
    [Abstract] [Full Text] [Related]

  • 10. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine.
    Grottick AJ, Corrigall WA, Higgins GA.
    Psychopharmacology (Berl); 2001 Sep 01; 157(3):292-8. PubMed ID: 11605085
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Hayes DJ, Mosher TM, Greenshaw AJ.
    Behav Brain Res; 2009 Feb 11; 197(2):323-30. PubMed ID: 18805442
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
    Hemrick-Luecke SK, Evans DC.
    Neuropharmacology; 2002 Feb 11; 42(2):162-9. PubMed ID: 11804612
    [Abstract] [Full Text] [Related]

  • 13. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C, Tessmer JL, Ullrich T, Rice KC, Walker PD.
    J Pharmacol Exp Ther; 2004 Aug 11; 310(2):687-94. PubMed ID: 15044557
    [Abstract] [Full Text] [Related]

  • 14. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
    Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB.
    Neuropsychopharmacology; 2009 Jul 11; 34(8):1958-67. PubMed ID: 19322172
    [Abstract] [Full Text] [Related]

  • 15. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar 11; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 16. Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.
    Zayara AE, McIver G, Valdivia PN, Lominac KD, McCreary AC, Szumlinski KK.
    Psychopharmacology (Berl); 2011 Feb 11; 213(2-3):321-35. PubMed ID: 20814782
    [Abstract] [Full Text] [Related]

  • 17. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H, Saito S, Sakurazawa S, Sasaki M, Usui T, Goto F.
    Pain; 2004 Mar 11; 108(1-2):163-9. PubMed ID: 15109520
    [Abstract] [Full Text] [Related]

  • 18. The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B.
    Scarlota LC, Harvey JA, Aloyo VJ.
    Psychopharmacology (Berl); 2011 Feb 11; 213(2-3):393-401. PubMed ID: 20652541
    [Abstract] [Full Text] [Related]

  • 19. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ, Grottick AJ, Menzaghi F, Reyes-Saldana H, Espitia S, Yuskin D, Whelan K, Martin M, Morgan M, Chen W, Al-Shamma H, Smith B, Chalmers D, Behan D.
    J Pharmacol Exp Ther; 2008 May 11; 325(2):577-87. PubMed ID: 18252809
    [Abstract] [Full Text] [Related]

  • 20. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
    Calcagno E, Carli M, Baviera M, Invernizzi RW.
    J Neurochem; 2009 Jan 11; 108(2):521-32. PubMed ID: 19046357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.